Growth hormone deficiency market overview (2026–2030) with industry insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Growth Hormone Deficiency Market Expected To Reach Based On Its 2026 Value?

The growth hormone deficiency market size has experienced strong expansion in recent years. It is anticipated to increase from $4.3 billion in 2025 to $4.55 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.9%. Historically, this market expansion can be ascribed to improved diagnostic capabilities for pituitary disorders, heightened awareness of growth hormone deficiency, the enlargement of pediatric endocrinology services, the availability of recombinant hormone treatments, and enhanced healthcare access.

The growth hormone deficiency market size is projected to experience robust expansion over the next few years. It is forecast to reach $5.67 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. This anticipated growth during the forecast period can be attributed to several factors, including an escalating demand for personalized hormone therapies, increasing investments in endocrine research, the expansion of home-based treatment administration options, the growing utilization of digital health monitoring tools, and a heightened focus on long-acting growth hormone formulations. Significant trends expected during this period include a greater adoption of recombinant growth hormone therapies, an increased use of personalized treatment approaches, a sharpened focus on the early diagnosis of hormonal disorders, the expansion of long-term hormone replacement programs, and enhanced monitoring of treatment outcomes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/growth-hormone-deficiency-global-market-report

What Leading Drivers Are Supporting The Growth Hormone Deficiency Market Expansion?

The increasing occurrence of genetic disorders is anticipated to fuel expansion in the growth hormone deficiency market moving forward. These conditions are defined as health issues stemming from DNA irregularities or mutations in an individual, which can be inherited or develop spontaneously. Factors contributing to the rise in genetic disorders include progress in diagnostic tools, heightened public awareness, an increase in maternal age, environmental elements inducing mutations, overall population growth, and better survival rates for those affected. Treatment for growth hormone deficiency serves to address growth-related issues found in specific genetic conditions. An illustrative example is from October 2024, where the Cystic Fibrosis Trust, a UK-based organization supporting individuals with cystic fibrosis, reported approximately 11,148 registered cystic fibrosis (a genetic disorder) patients in 2022. This figure rose to 11,318 in 2023, indicating a 1.5% year-over-year increase in patient registrations. Consequently, the expanding occurrence of genetic disorders is a primary force behind the expansion of the growth hormone deficiency market.

Which Segment Classifications Are Used In The Growth Hormone Deficiency Market Segment Analysis?

The growth hormone deficiency market covered in this report is segmented –

1) By Type: Pediatric Growth Hormone Deficiency, Adult Growth Hormone Deficiency

2) By Treatment: Pharmacological Therapy, Recombinant Human Growth Hormone

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

4) By End User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Pediatric Growth Hormone Deficiency: Idiopathic Growth Hormone Deficiency, Genetic Growth Hormone Deficiency, Acquired Growth Hormone Deficiency

2) By Adult Growth Hormone Deficiency: Primary Growth Hormone Deficiency, Secondary Growth Hormone Deficiency

What Emerging Trends Are Seen In The Growth Hormone Deficiency Market?

Major companies within the growth hormone deficiency market are concentrating on developing novel products, such as unmodified somatropin, for daily pediatric growth hormone deficiency (GHD) treatments. This unmodified somatropin refers to the identical growth hormone utilized in daily pediatric growth hormone deficiency treatments, but it is now delivered in a once-weekly dosage through Skytrofa. For instance, in September 2023, Ascendis Pharma A/S, a biopharmaceutical company located in Denmark, launched SKYTROFA (lonapegsomatropin) specifically for the once-weekly treatment of pediatric growth hormone deficiency (GHD). This innovative therapy provides increased convenience, improved adherence, and potentially superior treatment outcomes when compared to traditional daily growth hormone therapies. As the first and only FDA-approved once-weekly treatment for pediatric GHD, it represents a significant advancement in endocrinology and pediatric care.

Which Firms Are Contributing To The Growth Hormone Deficiency Market Ecosystem?

Major companies operating in the growth hormone deficiency market are Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Merck KGaA, Ipsen, Ascendis Pharma A/S, Opko Health Inc., Genentech Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., Ferring Pharmaceuticals, JCR Pharmaceuticals, LG Chem, BioPartners, GeneScience Pharmaceuticals, SciClone Pharmaceuticals, AnkeBio, Versartis, Aeterna Zentaris

Get The Full Growth Hormone Deficiency Market Report:

https://www.thebusinessresearchcompany.com/report/growth-hormone-deficiency-global-market-report

Which Region Dominates The Growth Hormone Deficiency Market By Market Share?

North America was the largest region in the growth hormone deficiency market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the growth hormone deficiency market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Growth Hormone Deficiency Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/growth-hormone-deficiency-global-market-report

Browse Through More Reports Similar to the Global Growth Hormone Deficiency Market 2026, By The Business Research Company

5 Alpha Reductase Deficiency Market Report 2026

https://www.thebusinessresearchcompany.com/report/5-alpha-reductase-deficiency-global-market-report

Combined Pituitary Hormone Deficiencies Market Report 2026

https://www.thebusinessresearchcompany.com/report/combined-pituitary-hormone-deficiencies-global-market-report

Hormone Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795